Huagai Capital
124
29M
107
10.33
32
0.13
8
- Stages of investment
- Areas of investment
Summary
Huagai Capital is the famous VC, which was founded in 2012. The leading representative office of defined VC is situated in the Beijing. The venture was found in Asia in China.
Opposing the other organizations, this Huagai Capital works on 17 percentage points less the average amount of lead investments. The typical startup value when the investment from Huagai Capital is 500 millions - 1 billion dollars. The fund is constantly included in 2-6 investment rounds annually. Speaking about the real fund results, this VC is 56 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2019. The increased amount of exits for fund were in 2018. The usual things for fund are deals in the range of 10 - 50 millions dollars.
The fund has exact preference in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Health Care, Pharmaceutical. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Tiger Brokers, EdiGene, Songxiaocai. For fund there is a match between the location of its establishment and the land of its numerous investments - China.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Huagai Capital, startups are often financed by Sequoia Capital China, Qiming Venture Partners, Qualcomm Ventures. The meaningful sponsors for the fund in investment in the same round are ZhenFund, Tranquility Capital, Sequoia Capital China. In the next rounds fund is usually obtained by Lilly Asia Ventures, IDG Capital, Green Pine Capital Partners.
This organization was formed by Lu Binghui, Xu Xiaolin. Besides them, we counted 2 critical employees of this fund in our database.
Investments analytics
Analytics
- Total investments
- 124
- Lead investments
- 32
- Exits
- 8
- Rounds per year
- 10.33
- Follow on index
- 0.13
- Investments by industry
- Health Care (38)
- Biotechnology (29)
- Medical (28)
- Pharmaceutical (13)
- Software (11) Show 124 more
- Investments by region
-
- China (113)
- United States (6)
- Canada (1)
- Peak activity year
- 2021
- Number of Unicorns
- 2
- Number of Decacorns
- 2
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 54M
- Group Appearance index
- 0.77
- Avg. company exit year
- 7
- Avg. multiplicator
- 4.21
- Strategy success index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Chuanxin Biotech | 01 Jan 2022 | Biotechnology, Medical | Seed | Jiangsu, Suzhou, China | |
| 10 May 2021 | Seed | Zhejiang, Lanxi, China |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.